"In patients with both COVID-19 and cancer, our team thought that immunotherapy might increase the immune system response, which could already be overactive because of the COVID-19 infection," researcher and UC postdoctoral fellow Layne Weatherford said.
Weatherford works in the lab of Trisha Wise-Draper, PhD, an associate professor of medicine, Division of Hematology Oncology, at the UC College of Medicine, UC Health oncologist and medical director of the UC Cancer Center Clinical Trials Office.
Read the full story, which was originially reported by HealthDay News and also featured on the WebMD website, Everyday Health and at Drugs.com.
Read the UC news release on this research.
Featured photo of test tubes by Colleen Kelley/UC Creative + Brand.